Biologic Medications for Rheumatoid Arthritis: Powerful Tools, But Not Always the First Choice

Understanding why the best treatment is not always the newest one

Introduction

When many people are diagnosed with rheumatoid arthritis, they quickly discover that there are now many different treatments available.

Among the most talked-about are biologic medications — advanced therapies that have transformed the lives of countless patients over the past two decades.

It is easy to assume that because these medications are newer and often more expensive, they must also be the best treatment for everyone.

Modern rheumatology is not about giving every patient the newest medication available. It is about choosing the treatment that offers the greatest benefit with the least unnecessary risk. For many patients, that treatment is still one of the conventional medications that have been used successfully for decades.

Understanding the Different Types of Treatment

The medications used to treat rheumatoid arthritis are often divided into three broad groups: conventional DMARDs, biologic medications, and targeted synthetic DMARDs (such as JAK inhibitors).¹ Rather than replacing one another, these treatments provide different options for different clinical situations.

The Quiet Success of Conventional DMARDs

Because biologic medications receive so much attention, it is easy to overlook just how successful conventional DMARDs have been. For many patients diagnosed early and treated appropriately, they provide excellent disease control, and many can achieve remission or low disease activity with early, appropriately adjusted treatment.¹,² Treatment usually begins with conventional DMARDs. Biologic or targeted synthetic DMARDs are considered when the treatment target is not reached despite an appropriate conventional DMARD strategy.¹,²

Why Don't We Start Everyone on Biologics?

If a simpler treatment is likely to achieve the same result, there is usually little advantage in choosing a more complex one. Medicine is not about using the strongest treatment available. It is about using the most appropriate treatment for the individual sitting in front of you.

Choosing the Right Treatment Rather Than the Most Expensive One

New discoveries are exciting, but innovation should never replace thoughtful clinical judgment. One of the most important principles in medicine is to use the least intensive treatment that can safely and effectively control the disease. The purpose of treatment is not to prescribe the newest drug. It is to achieve the best possible outcome for the patient.

You can read more about this decision-making process in How I Choose the Right Treatment.

When Biologics Can Be Life-Changing

For patients whose rheumatoid arthritis remains active despite appropriate conventional treatment, biologics have been one of the greatest advances in modern rheumatology. They have helped many people return to work, protect their joints, reduce pain, maintain independence, and improve quality of life.

There Is No Prize for Taking the Newest Medication

Patients sometimes feel disappointed when they are told they do not need a biologic medication. A patient whose rheumatoid arthritis is well controlled with a conventional DMARD has not received lesser treatment — they have received the treatment that best suits their disease. Success is measured by healthy joints, preserved function, and quality of life — not by the price of a medication or the year it was introduced.

Every Patient's Journey Is Different

No two patients with rheumatoid arthritis are exactly alike. Some achieve remission with a conventional DMARD alone, while others require biologic or targeted therapies. Treatment should always be individualized rather than following a single formula.

A Partnership That Evolves Over Time

Treatment is rarely static. Regular follow-up allows therapy to be tailored over time while maintaining the goals of controlling inflammation, preserving joint function, and protecting quality of life.

Frequently Asked Questions

How are biologic medications for rheumatoid arthritis administered?

Most biologics are given either as a self-administered injection under the skin, on a schedule that varies by medication, or as an intravenous infusion given at a clinic. Your rheumatologist will discuss which options are appropriate for the specific medication being considered and what the ongoing schedule would look like.

Are biologic medications safe? What are the main risks?

Biologics work by modifying parts of the immune system, so the main risk is an increased susceptibility to infection. Before starting treatment, patients are screened for chronic infections such as tuberculosis and hepatitis B and C, and monitored regularly throughout treatment.³ For most patients, the benefits of controlling active rheumatoid arthritis outweigh these risks, but this is always assessed individually.

Are biologic medications covered by insurance in the UAE?

Coverage varies significantly by insurer and plan. Message us on WhatsApp with your insurance details and we can check your specific coverage before any treatment decision is made.

How do I know if I need a biologic instead of a conventional DMARD?

Biologics are typically considered when rheumatoid arthritis remains active despite an adequate trial of conventional DMARDs, or in specific situations where your rheumatologist judges an earlier biologic may be appropriate.¹,² This is always an individualized decision based on your disease activity, history, and how you've responded to treatment so far.

How long does it take for biologics to start working?

This varies by medication and by individual, but many patients notice some improvement within a few weeks, with full effect often taking a few months to assess properly. Treatment response is formally reviewed against a target, with improvement expected by about three months and the treatment target reached by about six months.⁴ Your rheumatologist will schedule follow-up to track your response and adjust the plan if needed.

Can I switch from a biologic back to a conventional DMARD, or between biologics?

Yes. Treatment isn't a one-way decision — if a biologic isn't working well or side effects become a concern, there are usually other biologics or approaches to try, and treatment plans are reviewed and adjusted over time as part of ongoing care. In some cases, a biologic is used for a limited period specifically to bring active disease under control, after which a conventional DMARD alone may be enough to maintain that control going forward. Your rheumatologist will guide this decision based on how your disease responds over time.

A Final Thought

One of the greatest strengths of modern rheumatology is not simply that we have biologic medications — it is that we have choices. Conventional DMARDs remain remarkably effective for many patients, while biologic and targeted therapies have transformed outcomes for others. These treatments are not competitors; they complement one another. The best treatment is simply the one that is right for the person sitting in front of you.

If you have rheumatoid arthritis and would like to review your treatment plan, you can book an appointment with our rheumatology service at Dubai Healthcare City.